John Boehmer

May 22, 2024 | onlinelibrary.wiley.com | Michael Pfeiffer |John Boehmer |John Gorcsan |Shunsuke Eguchi

Introduction Interatrial shunt devices and catheters that create iatrogenic atrial septal defects (iASD) to decompress the left atrium in patients with heart failure (HF) are under investigation.1-7 Although most of these approaches create a shunt with orifice diameters that range from 0.6 to 1.0 cm, the actual orifice dimensions may vary depending on distortion caused by the topography of the interatrial septum or interventional placement methods.

Mar 6, 2023 | cfrjournal.com | Barry A. Borlaug |Joost Daemen |John Boehmer

Video ACC 23: Evaluation of the Mechanism of Benefit for Dapagliflozin in HFpEF Published: Views: 160 Likes: 0 ACC.23/WCC — In this short interview from the ACC's 2023 Scientific Sessions, Dr Barry Borlaug (Mayo Clinic, US) joins us virtually to discuss a trial which aims to evaluate the mechanism of benefit for dapagliflozin in patients with heart failure with preserved ejection fraction (Mayo Clinic).